Your browser doesn't support javascript.
loading
Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures.
Belov, Vladimir; Erwin-Grabner, Tracy; Aghajani, Moji; Aleman, Andre; Amod, Alyssa R; Basgoze, Zeynep; Benedetti, Francesco; Besteher, Bianca; Bülow, Robin; Ching, Christopher R K; Connolly, Colm G; Cullen, Kathryn; Davey, Christopher G; Dima, Danai; Dols, Annemiek; Evans, Jennifer W; Fu, Cynthia H Y; Gonul, Ali Saffet; Gotlib, Ian H; Grabe, Hans J; Groenewold, Nynke; Hamilton, J Paul; Harrison, Ben J; Ho, Tiffany C; Mwangi, Benson; Jaworska, Natalia; Jahanshad, Neda; Klimes-Dougan, Bonnie; Koopowitz, Sheri-Michelle; Lancaster, Thomas; Li, Meng; Linden, David E J; MacMaster, Frank P; Mehler, David M A; Melloni, Elisa; Mueller, Bryon A; Ojha, Amar; Oudega, Mardien L; Penninx, Brenda W J H; Poletti, Sara; Pomarol-Clotet, Edith; Portella, Maria J; Pozzi, Elena; Reneman, Liesbeth; Sacchet, Matthew D; Sämann, Philipp G; Schrantee, Anouk; Sim, Kang; Soares, Jair C; Stein, Dan J.
  • Belov V; Laboratory of Systems Neuroscience and Imaging in Psychiatry (SNIP-Lab), Department of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August University, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
  • Erwin-Grabner T; Laboratory of Systems Neuroscience and Imaging in Psychiatry (SNIP-Lab), Department of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August University, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
  • Aghajani M; Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Aleman A; Institute of Education and Child Studies, Section Forensic Family and Youth Care, Leiden University, Leiden, The Netherlands.
  • Amod AR; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Basgoze Z; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Benedetti F; Department of Psychiatry and Behavioral Science, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Besteher B; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bülow R; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
  • Ching CRK; Institute for Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Connolly CG; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Cullen K; Department of Biomedical Sciences, Florida State University, Tallahassee, FL, USA.
  • Davey CG; Department of Psychiatry and Behavioral Science, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Dima D; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.
  • Dols A; Department of Psychology, School of Arts and Social Sciences, City, University of London, London, UK.
  • Evans JW; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Fu CHY; Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Gonul AS; Experimental Therapeutics and Pathophysiology Branch, National Institute for Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Gotlib IH; School of Psychology, University of East London, London, UK.
  • Grabe HJ; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Groenewold N; SoCAT Lab, Department of Psychiatry, School of Medicine, Ege University, Izmir, Turkey.
  • Hamilton JP; Department of Psychology, Stanford University, Stanford, CA, USA.
  • Harrison BJ; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Ho TC; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Mwangi B; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Jaworska N; Center for Medical Imaging and Visualization, Linköping University, Linköping, Sweden.
  • Jahanshad N; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.
  • Klimes-Dougan B; Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
  • Koopowitz SM; Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Lancaster T; Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Li M; Center Of Excellence On Mood Disorders, Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Linden DEJ; Department of Psychiatry, McGill University, Montreal, QC, Canada.
  • MacMaster FP; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Mehler DMA; Department of Psychology, University of Minnesota, Minneapolis, MN, USA.
  • Melloni E; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Mueller BA; Cardiff University Brain Research Imaging Center, Cardiff University, Cardiff, UK.
  • Ojha A; MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Oudega ML; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
  • Penninx BWJH; Cardiff University Brain Research Imaging Center, Cardiff University, Cardiff, UK.
  • Poletti S; MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Pomarol-Clotet E; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Portella MJ; School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Pozzi E; Departments of Psychiatry and Pediatrics, University of Calgary, Calgary, AB, Canada.
  • Reneman L; Cardiff University Brain Research Imaging Center, Cardiff University, Cardiff, UK.
  • Sacchet MD; MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Sämann PG; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical School, RWTH Aachen University, Aachen, Germany.
  • Schrantee A; Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Sim K; Department of Psychiatry and Behavioral Science, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Soares JC; Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.
  • Stein DJ; Center for Neural Basis of Cognition, University of Pittsburgh, Pittsburgh, PA, USA.
Sci Rep ; 14(1): 1084, 2024 01 11.
Article en En | MEDLINE | ID: mdl-38212349
ABSTRACT
Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to date (N = 5365) to provide a generalizable ML classification benchmark of major depressive disorder (MDD) using shallow linear and non-linear models. Leveraging brain measures from standardized ENIGMA analysis pipelines in FreeSurfer, we were able to classify MDD versus healthy controls (HC) with a balanced accuracy of around 62%. But after harmonizing the data, e.g., using ComBat, the balanced accuracy dropped to approximately 52%. Accuracy results close to random chance levels were also observed in stratified groups according to age of onset, antidepressant use, number of episodes and sex. Future studies incorporating higher dimensional brain imaging/phenotype features, and/or using more advanced machine and deep learning methods may yield more encouraging prospects.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article